Publications
Detailed Information
Outcomes of partial gland ablation using high intensity focused ultrasound for prostate cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Sung Kyu | - |
dc.contributor.author | Lee, Hakmin | - |
dc.date.accessioned | 2022-09-30T05:53:34Z | - |
dc.date.available | 2022-09-30T05:53:34Z | - |
dc.date.created | 2022-06-17 | - |
dc.date.issued | 2022-05 | - |
dc.identifier.citation | Urologic Oncology: Seminars and Original Investigations, Vol.40 No.5, pp.193.e1-193.e5 | - |
dc.identifier.issn | 1078-1439 | - |
dc.identifier.uri | https://hdl.handle.net/10371/184933 | - |
dc.description.abstract | © 2022 Elsevier Inc.Background: To evaluate the clinical and oncological outcomes of partial gland ablation (PGA) using high intensity focused ultrasound (HIFU) technique for the clinically unilateral prostate cancer. Methods: We performed a retrospective analysis for the 163 patients who treated by PGA for clinically unilateral prostate cancer. The PGA was performed using Focal one system with concurrent trans-urethral prostatectomy. The oncological and functional outcomes were evaluated as well as risk factors for remnant disease after PGA. Clinically significant cancer was defined as grade group ≥2. Results: Among the entire subjects, grade group 2 or greater was present at pre-treatment biopsy in 76.7%. Median follow-up time was 17 months and 60.1% of total subjects had follow-up biopsy at postoperative 1 year. There were 25 subjects (24.2%) with any cancer and 13 subjects (12.6%) with CS cancer at the follow-up biopsy. The preoperative age and number of positive cores at preoperative biopsy were significantly associated with positive results at follow-up biopsy. Incontinence which requires 2 or more pads per day was observed at 4 subjects (2.5%) postoperatively. There were no subjects who needed intensive care or experienced rectal complications. Conclusion: The PGA with HIFU was safe and showed good preservation of functional outcomes as well as satisfactory oncological control. The remnant disease was observed in the 24.5% of patients who underwent follow-up biopsy in the present study. Thus, further prospective study is needed to evaluate oncological and functional outcomes of PGA with HIFU more accurately. | - |
dc.language | 영어 | - |
dc.publisher | Elsevier BV | - |
dc.title | Outcomes of partial gland ablation using high intensity focused ultrasound for prostate cancer | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.urolonc.2022.02.007 | - |
dc.citation.journaltitle | Urologic Oncology: Seminars and Original Investigations | - |
dc.identifier.wosid | 000831301100012 | - |
dc.identifier.scopusid | 2-s2.0-85127605799 | - |
dc.citation.endpage | 193.e5 | - |
dc.citation.number | 5 | - |
dc.citation.startpage | 193.e1 | - |
dc.citation.volume | 40 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Hong, Sung Kyu | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.